This is not a forecast. It is an inventory.
For two weeks, the Bitcoin Longevity Demographic survey has been in the field — a deliberately narrow instrument aimed at a deliberately overlooked intersection: people who hold New Wealth (Bitcoin) and spend seriously inside New Health (Longevity).
What follows is not the full dataset. It is the first cut: the shape of the wallet, the shape of the trust problem, and the shape of the refusal.
One. What we measured
We asked what people buy, what they distrust, what they will pay for without being nudged, and what makes them close a tab even when the product is good.
We also asked what they believe about time — because time preference is not only an economic variable. It is a hygiene variable. It determines whether a customer treats a diagnostic as a one-off panic purchase or as a multi-year relationship with a signal.
The most expensive mistake in premium wellness is not overpricing. It is misunderstanding who will still be listening after the novelty wears off.
Two. The 21-figure phrase is not theatre
Twenty-one is a Bitcoin-native number. “Figure” is a longevity-native word for consequence counted in years, not impressions.
Put plainly: the cohort we are describing carries concentrated purchasing power and concentrated scepticism in the same pocket. That combination is what makes the wallet “longevity-shaped” — not because the line items are all supplements and scans, but because the spending is oriented toward durability, verification, and second-order effects.
Three. What the demographic refuses to tolerate
Early returns cluster around three refusals.
First, performative urgency — the brand that treats the customer like a child who must be frightened into action.
Second, opacity dressed as science — the ingredient deck that reads like marketing copy, the study cited without context, the influencer endorsement mistaken for evidence.
Third, surveillance as a loyalty programme — the app that cannot explain why it needs what it asks for.
These refusals are not moral posturing. They are risk management.
Four. What we will publish next
On the 26th of June, we release the full dossier: category spend, openness to premium pricing, appetite for clinical depth, and the language that earns permission in this room.
Until then, treat this piece as a doorstop — something that keeps the hype from slamming shut on your foot while the numbers are still moving.
If you are a brand lead, the honest question is not whether you believe in Bitcoin. The question is whether you can serve a customer who treats belief as something you earn slowly — and keeps receipts.